chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Just before 12:30pm, after receiving my 2nd dose of Pfizer's Covid Vaccine on 9/12, I got a burning sensation in my right eye for about 20 minutes and then a migraine hit. I took an Excedrin, which helped with the pain a little bit, but the throbbing lasted until the next day, Monday 9/13, finally going away around 11am.  Monday night, 9/13, around 6pm, I started bleeding as if I started my menstrual cycle. At this point I was two months into taking Progesterone every single day and shouldn't have been bleeding at all. Monday night into Tuesday morning's flow was heavy but manageable. Tuesday afternoon between 6-7pm, my flow got even heavier. I bled through a size super tampon and pad within the hour. This carried into Wednesday, and I had to deal with such a heavy flow all day long. Wednesday night at 7:45pm I bled through through my pants only 30 minutes after inserting a fresh tampon and new pad. Thursday morning at 3:15am I woke up to blood soaked though my pants onto the bedsheet. This carried into Friday, gradually getting less heavy but still having to change my tampon and pad every hour. Saturday and Sunday were even less heavier, where I could go 2-3 hours between changes. The bleeding didn't stop until Monday. The amount of blood that I couldn't control was comparable to the postpartum bleeding I experienced with both of my children.
17 years old; A spontaneous report () was received from a healthcare professional concerning a 17-years-old  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced event 17 years old. The patient's medical history was not provided. No relevant concomitant medications were reported.  On 1 Mar 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 010A21A) intramuscularly in the right arm for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced the event 17 years old.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event, 17 years old was considered to be resolved at the time of this report.
This spontaneous case was reported by a consumer and describes the occurrence of GENERAL PHYSICAL HEALTH DETERIORATION (deteriorating), BONE DISORDER (has a bone sticking out) and DISORGANISED SPEECH (hard to try to organized her speech) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In December 2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced GENERAL PHYSICAL HEALTH DETERIORATION (deteriorating), BONE DISORDER (has a bone sticking out) and DISORGANISED SPEECH (hard to try to organized her speech). At the time of the report, GENERAL PHYSICAL HEALTH DETERIORATION (deteriorating), BONE DISORDER (has a bone sticking out) and DISORGANISED SPEECH (hard to try to organized her speech) had not resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Elderly and confused patient called to inform according to her doctor was ignoring her and doctor was not doing anything. No concomitant medications was reported. No treatment drug details was reported. This case was linked to MOD-2021-238873, MOD-2021-253505 (Patient Link).
lightheaded  increased blood pressure nausea clammy hands sweating a little  and tingling in legs and a little in arms
Acute redness and swelling lasting approximately 5 to 7 days, in left upper arm. Resolved with local heat. Now complaining of left should joint pain, decreased range of motion, "lame".
On 4/28/2021 the patient began to develop tiredness, dizziness, and a fall. The next day she went to her PCP who scheduled her for an MRI to check for TIA. The brain MRI was performed on 5/3/2021 and showed a small recent infarct involving the right corona radiata/deep white matter of the right parietal lobe. Patient was diagnosed with a CVA.
After the injection I had fever itching and a very large area of swelling. I call pharmacy and 1 of the doctors told me to take ADVIL for inflammation. The fever stopped after a week but the swelling and itching lasted longer. The swelling finally went away after 2 week but the itching stopped around the 6 or 7 of Dec.
slight headache after injection; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (slight headache after injection) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (slight headache after injection). At the time of the report, HEADACHE (slight headache after injection) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product information was not provided.  Treatment information was not provided.
Pt. says that night after getting vaccine; (L) deltoid was sore and soreness increased throughout the day. Saturday 12/20 increased (L) deltoid pain and hard to move (L) arm and felt feverish. Sunday c/o red rash around injection site and at 3-4 inches in diameter with slight itchiness. The rash spread to elbow and patient described it as patches down arm. Pt took BENADRYL over the weekend. Today, 12/23 pt is 95% better. (Denied shortness of breath, no cough, no swelling of lips, tongue or throat).
Patient began crying and developed persistent cough which worsened and eventually became somewhat weak.  Face red, hives on lower face and neck, lips swollen.  Mild wheezing.
After shot was administered then pt. told me she was pregnant. Didn't know to tell Gynecologist about the vaccine she received
I went and got tested on 01MAR2021, tested positive for COVID-19.; Lost smell; fatigue; sleeping; can't eat; headache; feeling sick; This is a spontaneous report from a non-contactable consumer (patient).  A female patient of an unspecified age received BNT162B2 (BNT162B2), formulation: Solution for injection, (Batch/Lot number was not reported, dose 1st via an unspecified route of administration, administered on 26Feb2021 as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On 27Feb2021 the patient had lost smell all the rest of the weekday's patient experienced fatigue, sleeping, could not eat and headache. The patient had no fever and cough but just kept feeling sick. On 01Mar2021 the patient had tested positive for COVID-19 and was on quarantine for 14 days. On 14Mar2021 the patient again went back and still tested positive for COVID-19. The patient was due for second dose 21Mar2021, but she couldn't go back. The patient was asked to wait for 90 days before second dose, the 3rd time she tested negative on 25MAR2021. It was reported that the patient had been told that she couldn't get the second dose however she wanted to get fully vaccinated. The patient was told that she had the antibodies and that she was protected by the nurse. Outcome of events was unknown.   No follow-up attempts are needed; Information about lot/batch number cannot be obtained.
1st dosein December 2020, should pt receive 2nd dose?; This case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose in December 2020).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The reporter was the patient's daughter. The age at vaccination was not applicable for this report. Till the time of reporting, the patient never get 2nd dose of Shingrix, which led to incomplete course of vaccination. The reporter asked, if the patient should receive the second dose now or restart the vaccine series. The reporter declined to provide additional details. The reporter did not consent to follow up.
Low grade fever (100.3) after one week with progressive weakness, fatigue and swallowing dysfunction analogous to exacerbation of her autoimmune disease (LUPUS) which had been in remission (on medication) for 5 years.
early September 2020 - jaw pain, right mandible went away but came back again around October Jaw pain stayed, headache also, daily. Increased pain as day wore on. Nov 17 Braces removed. Panorama xray showed no abnormalities. Complaining of headaches jaw pain, neck and upper back pain. Chiropractor visits Began late Nov., then jaw swelling in early Dec. Dentist xry on 12/ /2020 showed bone
Suspected vaccination failure; My Aunt / got the shingles; This case was reported by a consumer via interactive digital media (and described the occurrence of suspected vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows The reporter had reported for her//his aunt. The age at vaccination was not reported. After receiving Shingles vaccine, the patient still got shingles. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation were not provided.
On October 1, 2012, client reported that one day after receiving vaccines, he developed fever and an "explosion" in his left jaw. It was a popping sound then he developed pain and was unable to chew. He visited his dentist but did not receive any relief. He then visited his family doctor who rx Benadryl and antibiotic. He experienced some relief. Currently, client indicated that he cannot chew properly, his jaw is uneven and he continues to have pain.
Approximately 24 hrs. after receiving a ZOSTAVAX vaccination, the patient developed anterior chest pain, diffuse myalgias and mild headache. No reaction at injection site. No cough, diarrhea, nausea, vomiting, fever, chills. Symptoms spontaneously resolved mid-afternoon on 10/10/14.
I received my 2nd vaccine at 12:15 at the facility on Tuesday, Feb. 16.  At about 10:30 that night I began to feel a bit light headed.  I went to bed around 11:30 and didn't sleep very well.  On Wed. am after going to the bathroom, I felt woozy while washing my hands.  When I thought I felt better, I made my way back to the bedroom and passed out.  I fell on my right side, bruising the right side of my face, my right hip and my right thigh.  I apparently had my left hand under me when I fell because I broke the knuckle under the pinkie of my left hand.
Patient complained of feeling faint.  He stated, "I feel dizzy."  Suddenly lost consciousness in the moment following statement.  Client's breathing stopped.  No respirations noted.  Skin pale and clammy.  Epinephrine administered via left lateral thigh.  After administration, client immediately regained consciousness.  Appeared dazed and confused, stating, "What happened, how long was I out?"  He complained of extreme thirst.  911 called.  Emergency response arrived, assessed client.  They advised client to go to hospital.  Client declined.
Diverticulitis, chills, fever. Symptoms (chills, fever, and stomach pain) became pronounced around 3:00 p.m. but most likely began around 7:00 a.m., with the patient not recognizing the symptom as diverticulitis. Because the symptoms began before the actual immunization, the event is not related to the immunization, but since all adverse reactions were requested to be reported, the patient did so.
Systemic: Dizziness / Lightheadness-Mild, Systemic: Fainting / Unresponsive-Medium, Additional Details: Pt fainted a couple minutes after Pfizer 1st dose while she was sitting on the chair in the pharmacy waiting room and hit her head onto the floor. 911 was called and she was taken to hospital with complaint of her head hurts.
Case number PHEH2015US004137 is an initial spontaneous report received from medical assistant on 27 Feb 2015: This case refers to a 58 years old female patient. Past medical history and concomitant medications were not reported. The patient was vaccinated with FLUVIRIN (batch numbers: U5036CA, U501BAA, U5018AA, UI173AB, UI207AB, UI2O7AB, 14511F) at a dose of 0.5 intramuscularly on 05 Feb 2015, which reached 31 degree Fahrenheit for two hours. No adverse event was reported following this administration error.
rash from head to foot; sick; Initial information received on 30-Sep-2019 and Additional information was received on 02-Oct-2019 from same reporter regarding an unsolicited valid non-serious case received from a consumer.  This case involves a 81 years old female patient who experienced rash from head to foot and sick, while she received vaccines INFLUENZA VACCINE and INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV].  The patient's past medical history included Scoliosis. The patient's past vaccination(s) included FLUBLOK with past 3 or 4 years. The patient's past medical treatment(s) and family history were not provided. At the time of the event, the patient had ongoing Lung disorder and Drug hypersensitivity with allergic to neomycin, "polymycin.  On an unknown date, the patient received a dose of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE (lot number and Expiry date unknown) via unknown route in unknown administration site.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and Expiry date unknown) via unknown route in unknown administration site.  On an unknown date, the patient developed a non-serious rash from head to foot (rash generalised) and sick (malaise) (Unknown latency) following the administration of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE and INFLUENZA VACCINE.  (Other relevant tests included no lab data.) Final diagnosis was sick and rash from head to foot.  It was not reported if the patient received a corrective treatment.  The event outcome is reported as Unknown for rash from head to foot and sick.  Information on the batch number was requested.  Documents held by sender: none.
Pt began to lean to rt, eyes became fixed, face became flushed then pale, rigidity noted @ all times, could not bend head over, knees in sitting position; Became diaphoretic; no resp distress noted; tremor-like activity of upper extremities
He started with a sore throat and breathing issues. He then began vomiting but never had a temperature but was getting weak so I took him to the emergency room. They indicated that he had pneumonia and verified that he had COVID. He was admitted to the ICU on 02-11-2022. He is still currently being treated. He is on prolonged isolation.
CONFIRMED CLINICAL VACCINATION FAILURE; CONFIRMED COVID-19 INFECTION; This spontaneous report received from a patient concerned a male of unspecified age, race and ethnicity. The patient's height, and weight were not reported. The patient's concurrent conditions included: on dialysis. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of administration, and batch number were not reported, expiry: unknown) dose was not reported, 1 total, administered on MAR-2021 for prophylactic vaccination (Dose number in series 1). The batch number was not reported and has been requested. No concomitant medications were reported.  On 29-DEC-2021, the reporter reported that patient on dialysis, and went to the emergency room patient was not feeling right and had a bad cough. On the same date patient was diagnosed with positive COVID-19 polymerase chain reaction (PCR) test (confirmed covid-19 infection, and confirmed clinical vaccination failure). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of confirmed covid-19 infection, and confirmed clinical vaccination failure was not reported. This report was serious (Other Medically Important Condition). This report was associated with product quality complaint: 90000209586.; Sender's Comments: V0: 20211266620-Covid-19 vaccine ad26.cov2.s- Confirmed clinical vaccination failure. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS.
This case was reported by a consumer via call center representative and described the occurrence of injection site erythema in a female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced injection site erythema and injection site pain. On an unknown date, the outcome of the injection site erythema and injection site pain were recovered/resolved. It was unknown if the reporter considered the injection site erythema and injection site pain to be related to SHINGRIX. Additional details were provided as follows: This case was received via an e-mail during non business hours. The age at vaccination was not reported. About 2 months ago from the reporting date, the patient received the SHINGRIX vaccine and experienced the redness and soreness at the injection site. This case has been linked to case US2018GSK136649, reported by same reporter.
Information has been received from a physician via a company representative concerning a female patient who on 21-APR-2007 was vaccinated IM in the deltoid with a first dose of Gardasil. Concomitant therapy included Zyrtec. On 22-APR-2007 the patient went out in the  sun and experienced rash on her legs and on the arm she was given the injection. It was noted the that the rash was not itchy and lasted a couple of days before resolving completely. Unspecified medical attention was sought. Additional information has been requested.
Pt received Covid vaccine 10/19 at Outside facility and presented on 10/21 w/ left-sided weakness, found to have acute pontine infarction. low blood glucose
pt displayed lethargy & pallor w/in 2hr of vax;w/in 24hr of vax pt would not respond to stimuli or open eyes;t101;@ that time mom transferred pt to ER where tests & lab work were performed & pt was adm x 24hr;
First off, I do not know if this is related but I wanted to report in case other people found the same. We would not know of the issue if my daughter didn't have a medical procedure 4 days after her shot when she got heart rate checked. Pre-op on May 19 she went to pediatrician and have HR of 75. 3 days later got first Pfizer shot on 5/22. 4 days later on 5/26 she went to hospital in morning for a pre-planned laser treatment necessitating general anesthesia. Pre-anesthesia she had a resting heartrate of 38. Post - treatment it took a long time for her HR to stabilize and get close to 40 again.   Our pediatrician wants us to see a cardiologist but we couldn't get an appointment until June 22. She said hold off on 2nd vaccine until we meet cardiologists. She wants weekly vitals checks, yesterdays the HR was up to 55.  No clue if it's related but the night of the treatment when there was concern of her low HR I read about teens having heart issues after vaccine, so it made me wonder. The only thing that happened between 5/19 and 5/26 was her Pfizer shot and her HR went from 75 to 38 in that week.  Waiting for cardiologist but wanted to pass this along just in case. No other symptoms so we wouldn't have known if we hadn't checked her heart 4 days later!
Information has been received on 13-JAN-2017 from a nurse practitioner regarding a 16 year old female patient. The patient's concurrent conditions, medical history and concomitant therapy were not reported. The nurse practitioner reported that on 11-JAN-2017 the patient, who is pregnant, was vaccinated with GARDASIL 9 lot # L036301, expiration 20-DEC-2017, intramuscular for prophylaxis. On an unknown date, the patient had taken a urine pregnancy test. The LMP and EDD are not known. No side effects reported. No further information was reported. The outcome of exposure during pregnancy and no adverse event is unknown. Additional information has been requested.
Extremely exhausted; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (extremely exhausted) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B76A) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Apr-2021 at 7:00 AM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Apr-2021, the patient experienced FATIGUE (extremely exhausted). At the time of the report, FATIGUE (extremely exhausted) outcome was unknown. Not Provided          No concomitant medications were reported. No treatment medication was given to patient. Action taken with mRNA-1273 in response to the events was not applicable.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: Patient refused to provide email and denied further follow up.
Shortly after receiving vaccine, patient complained of fatigue and dizziness.  Blood pressure was measured as 156/97 mmHg and pulse was 69 bpm.  Patient stated he doesn't normally have high blood pressure.  Patient also started sweat.  Patient then declined any further treatment and was sent home with a ride (patient's mother-in-law).